Deltex Medical Group plc announced that Mr. Tim Irish and Mr. Mark Wippell have been appointed to the board as Non-Executive Directors, as of 16 June 2014. Tim has almost 30 years' experience in the healthcare industry, both in the UK and internationally, specifically in marketing medical products in a number of Deltex's key existing markets. Mark, a Partner with Allen & Overy LLP has significant experience advising international companies on their strategic transactions, including advising at Board level.
Delayed
Other stock markets
|
5-day change | 1st Jan Change | ||
0.115 GBX | 0.00% | 0.00% | -20.69% |
08/05 | TRADING UPDATES: ECO hails vaccine results; Plant Health sales down | AN |
02/04 | EARNINGS: AdvancedAdvT hails "good progress" after Capita deal | AN |
Chiffre d''affaires - Rate of surprise
1st Jan change | Capi. | |
---|---|---|
-20.69% | 27.75L | |
-15.37% | 281.78Cr | |
+1.11% | 19Cr | |
-17.50% | 8.07Cr | |
+10.14% | 5.07Cr |
- Stock Market
- Equities
- DEMG Stock
- News Deltex Medical Group plc
- Deltex Medical Group plc Announces Board Appointments